bpc-157 fda status or approved or banned 2026 Legal Status: Regulations and Compounding NBC News | The claims

If after a reasonable period of time there is a lack of satisfactory clinical response, dexamethasone sodium phosphate injection USP should be discontinued and the patient transferred to other appropriate therapy

Disguised Alpha prioritizes cGMP-certified capsule production, product documentation review, internal QA, and professional fulfillment instead of treating capsules as a generic white-label add-on

Some experts worry that broader availability to certain peptides through compounding pharmacies could expose larger numbers of patients to therapies whose long-term safety profiles remain unclear

Forbes, J., & Krishnamurthy, K

By week 68, 88.2% of those assigned to combination therapy remained on treatment